Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

4 Specialty Retail Stocks to Buy Now

The grades of four specialty retail stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

3 Service Stocks to Buy Now

This week, three service stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

3 Packaged Foods Stocks to Buy Now

The grades of three packaged foods stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Great Earnings Momentum — KNSY REGI BELFB STV BCR

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

4 Auto Parts Stocks to Buy Now

Four auto parts stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

3D Printing Companies DDD, SSYS & More: Buy on the Dip?

3D printing companies have had an incredible run, but recent news reports including a Barron's article have delivered a gut punch. What should you do now with stocks like DDD and SSYS?

Get Addicted to These 5 Stocks

These five businesses rely on addictive products and services, which means it's easy for them to keep customers coming back for more.

5 Stocks With Superb Cash Flow — YONG ZA GURE CHA CGA

This week, these five stocks have the best ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

4 Health Care Provider Stocks to Buy Now

The grades of four health care provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

Chipotle Stock is a Red-Hot Buy Right Now

Our Portfolio Grader has followed the rise in Chiptotle, as top and bottom line growth and fundamental improvement lifted Chipotle stock to an A rated buy

5 Stocks With Strong Earnings Growth — OME LRCX CODI INOC CNC

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

3 Distributors Stocks to Buy Now

This week, three distributors stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

2 Top Travel Stocks Trading Under $10

If you are looking for great value and a stock price that doesn't break the budget, look to smaller companies for value. Here are top travel stocks under $10

Fortegra Stock Is a Winner For Patient Investors

I chose Fortegra as a best stock pick for 2014, and despite recent setbacks, here's whey I'm still bullish on Fortegra stock for the rest of the year

5 Stocks With Superb Sales Growth — HTH INSY CREG TTWO GV

This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Superb Operating Margin Growth — AMAT RP PHM OSTK INOC

This week, these five stocks have the best ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

3 Sizzling Growth Stocks to Buy Under $20

3 Sizzling Growth Stocks Under $20 – Investment Ideas...

6 Capital Markets Stocks to Buy Now

The grades of six capital markets stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Bank of America – Should I Buy BAC Stock? 3 Pros, 3 Cons

BAC stock has been on a market-crushing tear for a long time. Is it time to sell -- or is there more upside ahead?